Etanercept treatment in corticosteroid-dependent myasthenia gravis.
Neurology
; 63(12): 2390-2, 2004 Dec 28.
Article
em En
| MEDLINE
| ID: mdl-15623708
ABSTRACT
The authors report a prospective pilot trial of etanercept in corticosteroid-dependent autoimmune myasthenia gravis. Eleven patients were enrolled, with eight completing the 6-month trial. Two patients were withdrawn owing to disease worsening, and one patient was withdrawn because of an erythematous skin rash. Six of the eight patients who completed the trial improved, based on quantitative measures of muscle strength and lowering of corticosteroid requirement.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Imunoglobulina G
/
Receptores do Fator de Necrose Tumoral
/
Miastenia Gravis
Idioma:
En
Ano de publicação:
2004
Tipo de documento:
Article